Showing results (441-450 of 2,345) with videos related to
Sort By:
Pageof 235
The AAPS Journal|January 5, 2017
Metabolic Profiling of Human Long-Term Liver Models and Hepatic Clearance Predictions from In Vitro Data Using Nonlinear Mixed-Effects ModelingNicole A Kratochwil, Christophe Meille, Stephen Fowler, et al.The AAPS Journal|January 11, 2017
Microdialysis Monitoring in Clinical Traumatic Brain Injury and Its Role in Neuroprotective Drug DevelopmentEric Peter Thelin, Keri L H Carpenter, Peter J Hutchinson, et al.The AAPS Journal|December 29, 2016
Exposure-Response and Tumor Growth Inhibition Analyses of the Monovalent Anti-c-MET Antibody Onartuzumab (MetMAb) in the Second- and Third-Line Non-Small Cell Lung CancerKelong Han, Pascal Chanu, Fredrik Jonsson, et al.The AAPS Journal|April 25, 2014
Anti-HIV drug development through computational methodsWan-Gang Gu, Xuan Zhang, Jun-Fa YuanThe AAPS Journal|April 8, 2014
Mapping the target localization and biodistribution of non-radiolabeled VMAT2 ligands in rat brainAifang Deng, Xianying Wu, Xue Zhou, et al.The AAPS Journal|May 1, 2008
Cell cycle checkpoint models for cellular pharmacology of paclitaxel and platinum drugsArdith W El-Kareh, Rachel E Labes, Timothy W SecombThe AAPS Journal|May 1, 2008
Informatic tools and approaches in postmarketing pharmacovigilance used by FDAJoyce Weaver, Mary Willy, Mark AviganThe AAPS Journal|May 1, 2008
Prodrug approaches for CNS deliveryJarkko Rautio, Krista Laine, Mikko Gynther, et al.The AAPS Journal|May 1, 2008
FDA critical path initiatives: opportunities for generic drug developmentRobert A LionbergerThe AAPS Journal|May 1, 2008
Pharmacogenetic and metabolic differences between dog breeds: their impact on canine medicine and the use of the dog as a preclinical animal modelSteven Fleischer, Michele Sharkey, Katrina Mealey, et al.Pageof 235